- Home
- CMI vs TAK Comparison
CMI vs TAK Comparison
Compare CMI & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMI
- TAK
- Stock Information
- Founded
- CMI 1919
- TAK 1781
- Country
- CMI United States
- TAK Japan
- Employees
- CMI N/A
- TAK N/A
- Industry
- CMI Industrial Machinery/Components
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- CMI Industrials
- TAK Health Care
- Exchange
- CMI Nasdaq
- TAK Nasdaq
- Market Cap
- CMI 39.3B
- TAK 45.8B
- IPO Year
- CMI N/A
- TAK N/A
- Fundamental
- Price
- CMI $338.83
- TAK $14.68
- Analyst Decision
- CMI Buy
- TAK
- Analyst Count
- CMI 11
- TAK 0
- Target Price
- CMI $362.45
- TAK N/A
- AVG Volume (30 Days)
- CMI 752.9K
- TAK 2.2M
- Earning Date
- CMI 07-31-2025
- TAK 07-30-2025
- Dividend Yield
- CMI 2.15%
- TAK 3.70%
- EPS Growth
- CMI 47.91
- TAK N/A
- EPS
- CMI 20.10
- TAK 0.45
- Revenue
- CMI $33,873,000,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- CMI N/A
- TAK $1.01
- Revenue Next Year
- CMI $5.87
- TAK $1.04
- P/E Ratio
- CMI $16.89
- TAK $65.09
- Revenue Growth
- CMI N/A
- TAK 7.45
- 52 Week Low
- CMI $260.02
- TAK $12.80
- 52 Week High
- CMI $387.90
- TAK $15.53
- Technical
- Relative Strength Index (RSI)
- CMI 63.96
- TAK 41.31
- Support Level
- CMI $325.25
- TAK $14.93
- Resistance Level
- CMI $344.30
- TAK $15.14
- Average True Range (ATR)
- CMI 6.68
- TAK 0.15
- MACD
- CMI 1.36
- TAK -0.06
- Stochastic Oscillator
- CMI 84.97
- TAK 11.86
About CMI Cummins Inc.
Cummins is the top manufacturer of diesel engines used in commercial trucks, off-highway machinery, and railroad locomotives, in addition to standby and prime power generators. The company also sells powertrain components, which include transmissions, turbochargers, aftertreatment systems, and fuel systems. Cummins is in the unique position of competing with its primary customers, heavy-duty truck manufacturers, who make and aggressively market their own engines. Despite robust competition across all its segments and increasing government regulation of carbon emissions, Cummins has maintained its leadership position in the industry.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.